Wellstat Therapeutics Corporation Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
Wellstat Therapeutics Corporation is a biotechnology research company based in Gaithersburg, Maryland. It operates with a small to mid-sized team and participates in the life sciences sector. In July 2023, the company completed the sale of assets to SERB Pharmaceuticals, including two medicines, Vistogard and Xuriden, both tied to uridine triacetate. The transaction shows Wellstat's involvement in asset disposition within the biotechnology market. The available information does not include founding details or current strategic direction.